Celldex Therapeutics, Inc. (CLDX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $121k
- Dec 4 · No plan
- Form 4 sales
- 40
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJun 3 2024
Sold 58,369 shares at $33.65 ($2M)
Heath-Chiozzi Margo, SVP OF REGULATORY AFFAIRS
No 10b5-1 planSold 81.3% of holdings ($2.4M position)13,383 shares leftFiling
- 2 Form 4 saleUnusualJun 7 +4 days
Sold 45,000 shares at $35.26 ($1.6M)
Young Diane C., SVP, CHIEF MEDICAL OFFICER
No 10b5-1 planSold 95.5% of holdings ($1.7M position)2,115 shares leftFiling
- 3 Form 4 saleUnusualJun 7 same day
Sold 15,000 shares at $35.06 ($526k)
Crowley Elizabeth, SR. VP & CPDO
No 10b5-1 planSold 62.3% of holdings ($844k position)9,074 shares leftFiling
- 4 Form 4 saleUnusualJun 14 +7 days
Sold 30,000 shares at $34.87 ($1M)
Crowley Elizabeth, SR. VP & CPDO
No 10b5-1 planSold 76.8% of holdings ($1.4M position)9,074 shares leftFiling
- 5 Form 4 saleUnusualJun 14 same day
Sold 17,172 shares at $35.42 ($608k)
Martin Samuel Bates, SVP AND CFO
No 10b5-1 planSold 37.9% of holdings ($1.6M position)28,125 shares leftFiling
- 6 Form 4 saleNo planAug 13 +425 days
Sold 771 shares at $24.77 ($19k)
Jimenez Freddy A., SVP & GENERAL COUNSEL
No 10b5-1 planSold 2.2% of holdings ($885k position)34,962 shares leftFiling
- 7 Form 4 saleUnusualNov 13 +92 days
Sold 49,298 shares at $24.00 ($1.2M)
Wright Richard M., Other
No 10b5-1 planSold 70.3% of holdings ($1.7M position)20,833 shares leftFiling
- 8 Form 4 saleNo planDec 4 +21 days
Sold 4,166 shares at $29.10 ($121k)
Jimenez Freddy A., SVP & GENERAL COUNSEL
No 10b5-1 planSold 11.9% of holdings ($1M position)30,796 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (40)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Form 4 sale | 4,166 | $121k | 11.9% | No plan | SEC |
| Nov 13, 2025 | Wright Richard M. | Other | Form 4 sale | 49,298 | $1.2M | 70.3% | Unusual | SEC |
| Aug 13, 2025 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Form 4 sale | 771 | $19k | 2.2% | No plan | SEC |
| Jun 14, 2024 | Martin Samuel Bates | SVP AND CFO | Form 4 sale | 17,172 | $608k | 37.9% | Unusual | SEC |
| Jun 14, 2024 | Crowley Elizabeth | SR. VP & CPDO | Form 4 sale | 30,000 | $1M | 76.8% | Unusual | SEC |
| Jun 7, 2024 | Crowley Elizabeth | SR. VP & CPDO | Form 4 sale | 15,000 | $526k | 62.3% | Unusual | SEC |
| Jun 7, 2024 | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Form 4 sale | 45,000 | $1.6M | 95.5% | Unusual | SEC |
| Jun 3, 2024 | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | Form 4 sale | 58,369 | $2M | 81.3% | Unusual | SEC |
| Jun 3, 2024 | Wright Richard M. | SR. VP & CCO | Form 4 sale | 46,844 | $1.6M | 69.2% | Unusual | SEC |
| Jun 3, 2024 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Form 4 sale | 8,006 | $269k | 23.6% | No plan | SEC |
| May 30, 2024 | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | Form 4 sale | 38,719 | $1.3M | 84.5% | Unusual | SEC |
| May 30, 2024 | Martin Samuel Bates | SVP AND CFO | Form 4 sale | 35,000 | $1.2M | 58.2% | Unusual | SEC |
| May 30, 2024 | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Form 4 sale | 20,853 | $703k | 91.8% | Unusual | SEC |
| May 30, 2024 | Crowley Elizabeth | SR. VP & CPDO | Form 4 sale | 38,597 | $1.3M | 81.0% | Unusual | SEC |
| Dec 7, 2022 | Keler Tibor | EXECUTIVE VP & CSO | Form 4 sale | 16,860 | $623k | 69.6% | Unusual | SEC |
| Aug 18, 2022 | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Form 4 sale | 32,667 | $1.2M | 96.2% | Unusual | SEC |
| Aug 17, 2022 | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Form 4 sale | 19,000 | $709k | 90.0% | Unusual | SEC |
| Aug 15, 2022 | Marucci Anthony S | PRESIDENT & CEO | Form 4 sale | 120,000 | $4.5M | 81.3% | Unusual | SEC |
| Aug 15, 2022 | Wright Richard M. | SR. VP & CCO | Form 4 sale | 15,328 | $578k | 98.7% | Unusual | SEC |
| Aug 12, 2022 | Martin Samuel Bates | SVP AND CFO | Form 4 sale | 20,000 | $730k | 45.1% | Unusual | SEC |
| Dec 23, 2021 | Martin Samuel Bates | SVP and CFO | Form 4 sale | 9,500 | $399k | 28.0% | Unusual | SEC |
| Dec 8, 2021 | Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Form 4 sale | 7,323 | $293k | 94.7% | Unusual | SEC |
| Dec 8, 2021 | Crowley Elizabeth | Sr. VP &CPDO | Form 4 sale | 4,000 | $160k | 45.8% | Unusual | SEC |
| Dec 8, 2021 | Heath-Chiozzi Margo | SVP of Regulatory Affairs | Form 4 sale | 600 | $24k | 5.1% | Plan not stated | SEC |
| Nov 15, 2021 | Martin Samuel Bates | SVP and CFO | Form 4 sale | 9,500 | $414k | 26.1% | Unusual | SEC |
| Nov 12, 2021 | Young Diane C. | SVP, Chief Medical Officer | Form 4 sale | 4,600 | $198k | 68.5% | Unusual | SEC |
| Nov 1, 2021 | Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Form 4 sale | 7,323 | $317k | 94.7% | Unusual | SEC |
| Nov 1, 2021 | Crowley Elizabeth | Sr. VP &CPDO | Form 4 sale | 4,317 | $187k | 47.7% | Unusual | SEC |
| Nov 1, 2021 | Heath-Chiozzi Margo | SVP of Regulatory Affairs | Form 4 sale | 600 | $25k | 5.1% | Plan not stated | SEC |
| Aug 10, 2021 | Martin Samuel Bates | SVP and CFO | Form 4 sale | 2,738 | $124k | 8.5% | Plan not stated | SEC |
| Dec 14, 2020 | Wright Richard M. | Sr. VP & CCO | Form 4 sale | 20,832 | $388k | 99.0% | Unusual | SEC |
| Nov 23, 2015 | Catlin Avery W | Sr. VP & CFO | Form 4 sale | 25,000 | $450k | 41.6% | Unusual | SEC |
| Jun 15, 2015 | Catlin Avery W | Sr. VP & CFO | Form 4 sale | 25,000 | $615k | 50.4% | Unusual | SEC |
| Dec 6, 2013 | Lipton Karen Shoos | Director | Form 4 sale | 17,728 | $434k | 57.1% | Unusual | SEC |
| Dec 6, 2013 | Penner Harry Jr | Director | Form 4 sale | 17,728 | $434k | 56.9% | Unusual | SEC |
| Dec 6, 2013 | Ellberger Larry | Director | Form 4 sale | 17,728 | $434k | 41.5% | Unusual | SEC |
| Dec 6, 2013 | Catlin Avery W | Sr. VP & CFO | Form 4 sale | 183,333 | $4.5M | 92.9% | Unusual | SEC |
| Jun 24, 2009 | Medarex INC | 10% owner | Form 4 sale | 2M | $14.3M | 40.3% | Unusual | SEC |
| Sep 10, 2008 | Parekh Rajesh R | Director | Form 4 sale | 56,223 | $630k | 100.0% | Unusual | SEC |
| Jun 23, 2008 | Medarex INC | 10% owner | Form 4 sale | 351,691 | $4.3M | 6.6% | Plan not stated | SEC |